MIF and breast cancer: Recent mechanistic insights have revealed that breast cancer stem cells (BCSCs) can secrete macrophage migration inhibitory factor (MIF), which activates the WNT/β-catenin signaling axis, subsequently upregulating MYC and its downstream effector, the glycolytic enzyme ALDOC.